Phil B.FontanarosaMD, Deputy EditorIndividualAuthorMargaret A.WinkerMD, Deputy EditorIndividualAuthorStephen J.LurieMD, PhD, Fishbein FellowIndividualAuthor
In Reply: The clarifications provided by Drs
Ohkubo and Imai on the Ohasama study,1 the
first population-based study on the prognostic significance of ambulatory
BP, are consistent with our results of the Systolic Hypertension in Europe
Trial (Syst-Eur).2 Both studies demonstrated
that even after adjustment for conventional BP measurements, the 24-hour BP
remained linearly and significantly correlated with cardiovascular mortality.
We agree with the proposition that 24-hour ambulatory BP, irrespective of
the population studied, is a better predictor of cardiovascular risk than
Staessen JA, Fagard R, Thijs L, . Predicting Cardiovascular Risk Using Ambulatory Blood Pressure—Reply. JAMA. 2000;283(4):475–476. doi:10.1001/jama.283.4.475
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: